Aave Labs has introduced a governance proposal for a new lending system, "Custodied Collateral Lending: Aave V4 Isolated Hub & Spoke," enabling institutions to borrow stablecoins against Bitcoin held in Anchorage Digital custody. This model utilizes non-transferable Custodied Collateral Tokens (CoCTs) to represent off-chain collateral, with Chainlink's CustodySync managing their minting and burning. Liquidations will occur over-the-counter, and the system will be separate from Aave's retail markets, requiring approval from Aave DAO token holders.
For readers following Aave's institutional lending proposal, here is Pluang's market snapshot as of Sep 16, 2026 07:21 WIB: of 50 priced major cryptocurrencies tradable on Pluang, 4 rose and 45 fell today. Among them, THETA saw 95% Sell / 5% Buy order activity with a typical hold time on Pluang of 77 Days, while XTZ had 3% Sell / 97% Buy order activity and a typical hold time on Pluang of 100 Days.
Constellation Brands reported earnings per share of $3.74, surpassing analyst estimates of $3.55, and revenue of $2.63 billion, exceeding the $2.54 billion forecast. The company saw a 5% increase in beer sales and a 17% rise in wine and spirits sales...
Tilray Brands will announce its fiscal Q1 2027 earnings on October 8, with analysts forecasting a loss of $0.16-$0.19 per share on revenues around $265-$268 million, marking about 26% growth from last year. Investors will focus on cannabis and bevera...
On October 6, 2026, five notable stocks surged between 20.9% and 52.7%, driven by various positive developments. Apimeds Pharmaceuticals rose 52.7% after its subsidiary signed a blockchain contract, while Option Care Health gained 32.7% following a $...
On October 6, five notable stocks saw significant declines, with losses ranging from 17.5% to 50.1%. ArriVent BioPharma's shares plunged 46.9% after its lung cancer treatment failed to meet the primary endpoint in a Phase 3 trial. Armada Acquisition ...
Evercore ISI raised its price target for Marvell Technology to $433 from $275, maintaining an Outperform rating. This follows Marvell's optimistic revenue projections, expecting $20 billion by fiscal 2028 and $70-$90 billion by fiscal 2031, driven by...
